These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6049729)

  • 1. Aetiology of multiple sclerosis.
    Bernsohn J; Stephanides LM
    Nature; 1967 Aug; 215(5103):821-3. PubMed ID: 6049729
    [No Abstract]   [Full Text] [Related]  

  • 2. Relevance of fatty acids in multiple sclerosis.
    Mertin J; Meade CJ
    Br Med Bull; 1977 Jan; 33(1):67-71. PubMed ID: 318891
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple sclerosis: a survey of alternative hypotheses concerning aetiology, pathogenesis and predisposing factors.
    Ford HC
    Med Hypotheses; 1987 Oct; 24(2):201-7. PubMed ID: 3683248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALTERATIONS IN MYELIN FATTY ACIDS AND PLASMALOGENS IN MULTIPLE SCLEROSIS.
    GERSTL B; TAVASTSTJERNA MG; HAYMAN RB; ENG LF; SMITH JK
    Ann N Y Acad Sci; 1965 Mar; 122():405-16. PubMed ID: 14313500
    [No Abstract]   [Full Text] [Related]  

  • 5. Fatty acid pattern of lymphocytes in multiple sclerosis patients after high doses of maxEPA.
    Rosnowska M; Cendrowski W
    Mater Med Pol; 1987; 19(4):239-41. PubMed ID: 3454832
    [No Abstract]   [Full Text] [Related]  

  • 6. Fatty acid metabolism in multiple sclerosis.
    Thompson RH
    Biochem J; 1972 Jun; 128(1):4P. PubMed ID: 5085625
    [No Abstract]   [Full Text] [Related]  

  • 7. [On changes of some fatty acids with 18 carbon atoms in demyelination plaques in multiple sclerosis. Their significance in the mechanisms of demyelination].
    Amaducci L; Pazzagli A
    Riv Patol Nerv Ment; 1966 Aug; 87(4):329-50. PubMed ID: 5988024
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Multiple sclerosis.
    Heathcote JG
    Lancet; 1975 Feb; 1(7902):344. PubMed ID: 46495
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple sclerosis. Recent concepts of etiology.
    Davis TE
    Minn Med; 1974 Dec; 57(12):955-7. PubMed ID: 4421490
    [No Abstract]   [Full Text] [Related]  

  • 10. Brain fatty acid elongation and multiple sclerosis.
    Yatsu FM; Moss S
    Nature; 1970 Sep; 227(5263):1132-3. PubMed ID: 5451105
    [No Abstract]   [Full Text] [Related]  

  • 11. Aetiology of multiple sclerosis.
    Adams DH; Dickinson JP
    Lancet; 1974 Jun; 1(7868):1196-9. PubMed ID: 4135000
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fatty acid composition of cholesterol esters of the cerebral white substance in multiple sclerosis. (Preliminary note)].
    Borri PF; Bertinelli RP; Toso V; Taramelli M; Paci M; Pacini A
    Acta Neurol (Napoli); 1969; 24(4):593-602. PubMed ID: 5402754
    [No Abstract]   [Full Text] [Related]  

  • 13. Proteomics of a conundrum: Thoughts on addressing the aetiology versus progression of multiple sclerosis.
    Partridge MA; Myers SJ; Gopinath S; Coorssen JR
    Proteomics Clin Appl; 2015 Oct; 9(9-10):838-43. PubMed ID: 25580822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid metabolism in multiple sclerosis.
    Thompson RH
    Biochem Soc Symp; 1972; (35):103-11. PubMed ID: 4614798
    [No Abstract]   [Full Text] [Related]  

  • 15. [Synthetic concept on the pathogenesis of multiple sclerosis and of related demyelinating diseases].
    LESNY I; POLACEK L
    Cas Lek Cesk; 1956 Apr; 95(14):377-81. PubMed ID: 13316814
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of diet on the fatty acid compositions of serum, brain, brain mitochondria and myelin in the rat.
    Rathbone L
    Biochem J; 1965 Dec; 97(3):620-8. PubMed ID: 5881652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fatty acid composition of the plaques of demyelination in multiple sclerosis].
    Amaducci L; Pazzagli A; Petruzzi E
    Riv Patol Nerv Ment; 1965 Aug; 86(4):531-46. PubMed ID: 5870836
    [No Abstract]   [Full Text] [Related]  

  • 18. Fatty acids in spinal fluid and serum of patients with demyelinating disorders.
    TUNA N; LOGOTHETIS J; KAMMERECK R
    Neurology; 1963 May; 13():381-5. PubMed ID: 13994769
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fatty diet and multiple sclerosis].
    de Andrés C; Lledó A
    Rev Neurol; 1997 Dec; 25(148):2032-5. PubMed ID: 9528051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid chemistry of the brain in demyelinating diseases.
    CUMINGS JN
    Brain; 1955; 78(4):554-63. PubMed ID: 13293269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.